differential a.c. eeg amplifiers (AstroNova)
90
Structured Review
AstroNova
differential a.c. eeg amplifiers
Differential A.C. Eeg Amplifiers, supplied by AstroNova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differential+a%2Ec%2E+eeg+amplifiers/differential+a+c++eeg+amplifiers/pm22988063-54-4-8
Average 90 stars, based on 1 article reviews
Differential A.C. Eeg Amplifiers, supplied by AstroNova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differential+a%2Ec%2E+eeg+amplifiers/differential+a+c++eeg+amplifiers/pm22988063-54-4-8
Average 90 stars, based on 1 article reviews
differential a.c. eeg amplifiers - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Activity Assay:Article Title: Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization. Article Snippet: Nicotinic acetylcholine receptor (nAChR) agonists improve sensory gating deficits in animal models and schizophrenic patients.. The aim of this study was to determine whether the novel and selective 7 nAChR full agonist 5-(6-[(3R)-1-azabicyclo[2.2.2]oct3-yloxy]pyridazin-3-yl)-1H-indole (ABT-107) improves sensory gating deficits in DBA/2 mice.. Sensory gating was measured by recording hippocampal-evoked potential P20-N40 waves and determining gating test/conditioning (T/C) ratios in a paired auditory stimulus paradigm. Amplification:Article Title: Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization. Article Snippet: Nicotinic acetylcholine receptor (nAChR) agonists improve sensory gating deficits in animal models and schizophrenic patients.. The aim of this study was to determine whether the novel and selective 7 nAChR full agonist 5-(6-[(3R)-1-azabicyclo[2.2.2]oct3-yloxy]pyridazin-3-yl)-1H-indole (ABT-107) improves sensory gating deficits in DBA/2 mice.. Sensory gating was measured by recording hippocampal-evoked potential P20-N40 waves and determining gating test/conditioning (T/C) ratios in a paired auditory stimulus paradigm. |